Intellectual Property | Intellepedia

IP Career in India – Choices and Opportunities

The article examines the diverse career paths within Intellectual Property in India, including patents, trademarks, and copyrights. It discusses the necessary qualifications and the interdisciplinary skills required for success in the field, providing a structured overview for aspiring IP professionals.

Flipkart sends legal notice to blogger

Flipkart sent a legal notice to blogger Amit Bhawani for alleged trademark misuse and cybersquatting related to a comparison website. The case underscores the legal risks for websites using company names for surveys or polls.

And the lawsuit goes to….

Recently the Internet domain registrar, GoDaddy had its Oscar-worthy moment, winning against the Academy of Motion Picture Arts and Sciences (‘Academy’ for brevity). The Academy...

TiVo and Patent Infringement

TiVo has sued Samsung for allegedly infringing four of its multimedia technology patents, targeting both set-top boxes and mobile devices. This litigation highlights TiVo’s ongoing strategy to protect its intellectual property amid evolving market dynamics.

Ericsson has a (i)Ball at the Court

The Delhi High Court granted an interim injunction to Ericsson against iBall in a significant patent infringement dispute involving standard essential patents for mobile technologies. The court found in favour of Ericsson, stressing the importance of prompt patent rights enforcement in India.

Tequila’s Indian Cousin

An Indian food scientist has patented a process to produce tequila-like alcohol from Agave albomarginata, a plant native to the Rayalseema region. The innovation uses the plant’s high-starch pith, yielding a natural, cost-effective spirit called Naturohol.

Pfizer files for Patent on Known Substance

This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether unpublished patent applications can render a substance as “known” and critiques the merging of novelty and subject matter analysis.

Pfizer falls prey to Section 3(d)

This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence of enhanced efficacy in pharmaceutical patent applications.

Intellectual Property (IP) in India: A Decade of Progress Part 13

This post examines the progress of geographical indications in India, with a focus on key agricultural and food products that have secured GI status. It also outlines the legal measures taken to safeguard these products’ distinct reputations.

Working of Patents – A Workable Proposition?

This article critically examines the working of patents in India, focusing on statutory requirements, compulsory licensing, and judicial interpretations. It discusses both commercial and non-commercial working, highlighting the practical complexities faced by patentees under the Indian Patents Act.